Laboratorios SALVAT SA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Laboratorios SALVAT SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013999
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Laboratorios SALVAT SA (SALVAT) is a manufacturer of pharmaceutical products for healthcare industries. The company offers prescription and over-the- counter drugs in various segments such as personal healthcare, metabolism, urology, ophtholmology, dermatology and malaria. Its personal healthcare product portfolio includes bester complex, magnesium pyre, protransitus, nutira, urosens, levogastrol, salvarina, neomicina, and vincigrip among others. SALVAT’s metabolism segment offers fisiobil, meteoril and nutira, and others. The company’s activities also include blow-fill-seal contract manufacturing of small fill volume pharmaceutical unit dose sterile liquids such as ear drops and eye drops. It operates through a network of distributors in Europe, America, Asia and Africa, and the Middle East. SALVAT is headquartered in Barcelona, Spain.

Laboratorios SALVAT SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
iCo Therapeutics Enters into Licensing Agreement with Laboratorios SALVAT 10
Laboratorios SALVAT Enters into Licensing Agreement with Lee’s Pharma 11
Laboratorios SALVAT Enters into Licensing Agreement with Pediapharm 12
Laboratorios SALVAT Enters Into Licensing Agreement With FAES Farma 13
Laboratorios SALVAT Enters Into Licensing Agreement With Hyphens Pharma For CETRAXAL 14
Luqa Enters Into Licensing Agreement With Salvat For Cetraxal Plus 15
Salvat Enters Into Licensing Agreement With Luqa Ventures For Ebernet 16
Equity Offering 17
Loop Therapeutics Spin Off from Laboratorios SALVAT 17
Laboratorios SALVAT SA – Key Competitors 18
Laboratorios SALVAT SA – Key Employees 19
Laboratorios SALVAT SA – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Key Facts 2
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Laboratorios SALVAT SA, Deals By Therapy Area, 2011 to YTD 2017 8
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
iCo Therapeutics Enters into Licensing Agreement with Laboratorios SALVAT 10
Laboratorios SALVAT Enters into Licensing Agreement with Lee’s Pharma 11
Laboratorios SALVAT Enters into Licensing Agreement with Pediapharm 12
Laboratorios SALVAT Enters Into Licensing Agreement With FAES Farma 13
Laboratorios SALVAT Enters Into Licensing Agreement With Hyphens Pharma For CETRAXAL 14
Luqa Enters Into Licensing Agreement With Salvat For Cetraxal Plus 15
Salvat Enters Into Licensing Agreement With Luqa Ventures For Ebernet 16
Loop Therapeutics Spin Off from Laboratorios SALVAT 17
Laboratorios SALVAT SA, Key Competitors 18
Laboratorios SALVAT SA, Key Employees 19
Laboratorios SALVAT SA, Subsidiaries 20

★海外企業調査レポート[Laboratorios SALVAT SA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Helix Energy Solutions Group, Inc.:企業の戦略・SWOT・財務情報
    Helix Energy Solutions Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Helix Energy Solutions Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • CollPlant Ltd:医療機器:M&Aディール及び事業提携情報
    Summary CollPlant Ltd (CollPlant) is a regenerative medicine company that develops and commercializes tissue repair products. The company’s product categories include orthobiologics, wound care, and pipeline products. Its orthobiologics products comprise VergenixSTR and VergenixBVF. CollPlant’s woun …
  • Legian Beach Hotel:企業の戦略・SWOT・財務分析
    Legian Beach Hotel - Strategy, SWOT and Corporate Finance Report Summary Legian Beach Hotel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Liechtensteinische Landesbank Ag
    Liechtensteinische Landesbank Ag - Strategy, SWOT and Corporate Finance Report Summary Liechtensteinische Landesbank Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • bebe stores, inc.:企業の戦略・SWOT・財務分析
    bebe stores, inc. - Strategy, SWOT and Corporate Finance Report Summary bebe stores, inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Petroleos de Venezuela SA-エネルギー分野:企業M&A・提携分析
    Summary Petroleos de Venezuela SA (PDVSA) is a state-owned oil and gas company. It plans, coordinates, supervises, and controls the activities in the entire oil and gas value chain. The company explores for and develops oil and other hydrocarbons; refines, trades, and supplies that in domestic and o …
  • Euronet Worldwide Inc (EEFT):企業の財務・戦略的SWOT分析
    Euronet Worldwide Inc (EEFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Dyadic International Inc (DYAI):企業の財務・戦略的SWOT分析
    Summary Dyadic International Inc (Dyadic) is a biotechnology company that develops gene expression platform for production of industrial enzymes and other proteins. The company utilizes C1 technology, an expression system based on the fungus Myceliophthora thermophila, to discover and manufacture bi …
  • Nielsen Holdings PLC:企業の戦略・SWOT・財務分析
    Nielsen Holdings PLC - Strategy, SWOT and Corporate Finance Report Summary Nielsen Holdings PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Venn Life Sciences Holdings Plc (VENN):製薬・医療:M&Aディール及び事業提携情報
    Summary Venn Life Sciences Holdings Plc (Venn Life Sciences), formerly Armscote Investment Company Plc is a contract research organization that offers drug development, clinical trial management and resourcing solutions. The organization offers drug development services such as clinical pharmacology …
  • CVR Energy Inc (CVI):石油・ガス:M&Aディール及び事業提携情報
    Summary CVR Energy Inc (CVR Energy) is a diversified holding company that specializes in refining of crude oil and manufacturing of nitrogen fertilizer. It produces and sells high value transportation fuels such as gasoline, diesel, jet fuel, and gas oil. The company also produces pet coke and other …
  • iHeartMedia, Inc.:戦略・SWOT・企業財務分析
    iHeartMedia, Inc. - Strategy, SWOT and Corporate Finance Report Summary iHeartMedia, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Flowserve Corp (FLS):企業の財務・戦略的SWOT分析
    Flowserve Corp (FLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Rackspace Hosting, Inc.:企業の戦略・SWOT・財務情報
    Rackspace Hosting, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rackspace Hosting, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Diagnostica Stago SAS:企業の戦略的SWOT分析
    Diagnostica Stago SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • China State Shipbuilding Corp:企業の戦略・SWOT・財務分析
    China State Shipbuilding Corp - Strategy, SWOT and Corporate Finance Report Summary China State Shipbuilding Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • NetEnt AB (NET B):企業の財務・戦略的SWOT分析
    Summary NetEnt AB (NetEnt), formerly Net Entertainment NE AB, is a gaming solution provider. The company offers netent live, pooled jackpots, branded games, casinomodule, back office, touch, live casino and extend. It provides services such as business intelligence, regulated markets, iGaming media …
  • Tele2 AB (TEL2 B):企業の財務・戦略的SWOT分析
    Tele2 AB (TEL2 B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Hitachi Kokusai Electronic Inc.:企業の戦略・SWOT・財務情報
    Hitachi Kokusai Electronic Inc. - Strategy, SWOT and Corporate Finance Report Summary Hitachi Kokusai Electronic Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • PCI Pharma Services:製薬・医療:M&Aディール及び事業提携情報
    Summary PCI Pharma Services (PCI) is a pharmaceutical service provider that offers clinical, manufacturing and packaging solutions. The company offers clinical services such as clinical supplies management, clinical planning and support, project management, IVRS-IWRS, support services and data acces …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆